德克斯梅德托米丁用于痴呆症的激发:目前的数据和未来的方向
Kayla S Murphy1, Julia C Golden2, Rajesh R Tampi3
1Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Journal of the American Geriatrics Society
|September 19, 2024
概括
目前,没有完成的研究表明德克斯梅德托米丁可以有效地治疗痴呆症中的激动. 需要进一步的研究来确定其对痴呆症 (BPSD) 的行为和心理症状的安全性和有效性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
背景情况:
- 痴呆症的发病率和患病率正在上升,导致痴呆症 (BPSD) 的行为和心理症状增加.
- 有限的安全有效的治疗方法存在BPSD,特别是动荡.
- 德克斯梅德托米丁在治疗与狂妄症和其他疾病相关的激动症方面表现出有效性.
研究的目的:
- 调查德克斯梅德托米丁作为BPSD安全有效治疗的潜力,特别是痴呆症的激发性治疗.
- 审查关于使用德克斯梅德托米丁治疗痴呆相关激动现象的现有文献.
主要方法:
- 搜索了PubMed,Cochrane数据库和奥维德关于德克斯梅托米丁和痴呆症的研究.
- 包括英语语言的人类研究,无论研究类型如何.
- 专注于详细介绍德克斯梅德托米丁治疗痴呆症的报告.
主要成果:
- 没有确定已完成的研究,调查了德克斯梅德托米丁对痴呆症激发的作用.
- 目前正在进行TRANQUILITY研究,评估德克斯梅德托米丁对痴呆症激发的作用.
结论:
- 德克斯梅德托米丁在精神分裂症和双相情感障碍患者的医院妄和激动症方面已经证明有好处.
- 缺乏关于德克斯梅德托米丁用于痴呆症激发的已完成研究.
- 需要进行更大规模的受控研究来评估德克斯梅德托米丁在BPSD治疗中的有效性,安全性和最佳管理.
更多相关视频
12:41Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
4.2K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.8K
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
157
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
157
01:24Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
205
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
205
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:23Sedatives and Hypnotics: Overview
296
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
296
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
236
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
236